Merck to Buy U.S. Rights to Sentinel Brand for $400 Million
May 13 2020 - 6:28AM
Dow Jones News
By Colin Kellaher
Merck & Co. on Wednesday said it agreed to buy the U.S.
rights to Sentinel parasite-protection products for companion
animals from Virbac S.A. for $400 million in cash.
The Kenilworth, N.J., drug maker said the addition of Sentinel
Flavor Tabs and Sentinel Spectrum Chews complements its portfolio
of animal-health vaccines and pharmaceuticals.
Merck said it expects to complete the transaction by
mid-year.
Shares of French veterinary-medicines maker Virbac rose 9.8% to
EUR183.40.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 13, 2020 06:13 ET (10:13 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Merck (NYSE:MRK)
Historical Stock Chart
From Apr 2024 to May 2024
Merck (NYSE:MRK)
Historical Stock Chart
From May 2023 to May 2024